We are a boutique consulting firm specialised in ex-US business strategy for clinical stage assets
Over 20 engagements since 2019
Explore ex-US
A small investment in strategy can boost exit and option value.
What does it take?
A three-month independent review will give assessment of the upside, key development requirements and timeline, strategic option and timing for key decisions.
CEO viewpoint bridging R&D Commercial, Business Development and Finance
Strategic consultants with operational experience
Specialised in ex-US strategy of clinical stage assets: 10+ clients and 20+ projects since 2019
Independent professionals with no bias towards any strategy
Flexible and cost-effective set up to support pre-revenue stage enterprises
Livbio’s distinctive offer
Your ex-US business team
Client-focused, passionate and collegial team
Average of 30 years in the pharmaceutical sector
Ex-heads of International market access and regulatory
